Stay updated on Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s site revision label updated from **v3.5.2** to **v3.5.3** at the bottom of the ClinicalTrials.gov study page.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; this appears to be a backend/maintenance update with no visible changes to study details or page content.SummaryDifference0.0%

- Check68 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. No substantive study information appears to be altered.SummaryDifference0.0%

- Check90 days agoChange DetectedA revision tag was updated from v3.4.1 to v3.4.2, indicating a backend/content-management update with no evident impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision: v3.4.1 was added and the previous v3.4.0 revision was removed, indicating a minor update to the page's version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.